Fulcrum Therapeutics, Inc. (FULC)
3.76
-0.01
(-0.27%)
USD |
NASDAQ |
Sep 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Cash from Investing (Quarterly) : 13.78M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.78M |
| March 31, 2026 | -128.21M |
| December 31, 2025 | -1.049M |
| September 30, 2025 | 18.61M |
| June 30, 2025 | 13.93M |
| March 31, 2025 | -0.777M |
| December 31, 2024 | 2.26M |
| September 30, 2024 | 4.35M |
| June 30, 2024 | -12.51M |
| March 31, 2024 | 38.13M |
| December 31, 2023 | 18.35M |
| September 30, 2023 | 19.02M |
| June 30, 2023 | 19.88M |
| March 31, 2023 | -93.94M |
| December 31, 2022 | -36.36M |
| September 30, 2022 | -2.279M |
| June 30, 2022 | 31.40M |
| Date | Value |
|---|---|
| March 31, 2022 | 19.66M |
| December 31, 2021 | -9.094M |
| September 30, 2021 | -106.64M |
| June 30, 2021 | -26.35M |
| March 31, 2021 | 12.42M |
| December 31, 2020 | -14.60M |
| September 30, 2020 | 14.09M |
| June 30, 2020 | -0.226M |
| March 31, 2020 | -56.40M |
| December 31, 2019 | -0.108M |
| September 30, 2019 | -0.214M |
| June 30, 2019 | -0.221M |
| March 31, 2019 | -0.401M |
| December 31, 2018 | -3.466M |
| September 30, 2018 | -0.926M |
| June 30, 2018 | -3.806M |
| March 31, 2018 | -0.783M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 54.90M |
| Definium Therapeutics, Inc. | -315.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.04M |
| Cash from Financing (Quarterly) | 0.356M |
| Free Cash Flow | -66.14M |
| Free Cash Flow Per Share (Quarterly) | -0.2117 |
| Free Cash Flow to Equity (Quarterly) | -15.56M |
| Free Cash Flow to Firm (Quarterly) | -16.15M |
| Free Cash Flow Yield | -25.05% |